UNSPSC 51384509: Ibuprofen

This classification denotes a cyclooxygenase inhibitor with the molecular formula C13H18O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WK2XYI10QM, chemically known as u-18,573 but generally known as ibuprofen, which bears US NIH Compound Identifier 3672. European Medicines Agency schedules Ibuprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08098MIG. The term IBUPROFEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7).

UNSPSC 51384509 Ibuprofen is a Commodity code that, based on recent state and local solicitation activity, does not map cleanly to current procurement needs. The single recent opportunity tagged under this code — Seminole County, Florida's IFB 60459723LAS — solicits naloxone and drug deactivation systems, not ibuprofen or other over-the-counter pain relievers. The mismatch suggests either a coding error in the county's procurement system or that this particular code has been repurposed or misapplied in practice. State and local health departments and county public health authorities are the typical issuing bodies for pharmaceutical and medical-supply procurement, though the source provides no evidence of active ibuprofen-specific opportunities under this code.

Seminole County, Florida is the only recent buyer identified. The IFB, posted June 30, 2026 with a response deadline of July 26, 2023 (dates appear inconsistent in the source), calls for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. Vendors must include all shipping and delivery costs, comply with E-Verify and drug-free workplace requirements, carry workers' compensation and commercial general liability insurance, and accept a three-month probationary termination clause. The contract offers a two-year initial term with one-year renewal option and may be funded through FEMA. No explicit set-asides or disadvantaged-enterprise restrictions apply. The absence of additional recent ibuprofen solicitations and the dominance of a naloxone-focused opportunity suggest limited current market activity under this code in state and local procurement.